相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP PATH extension study
Ivo N. van Schaik et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Myasthenia gravis: Historical achievements and the golden age of clinical trials
Tam M. Nguyen-Cao et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis Exacerbations
Guntis Karelis et al.
EUROPEAN NEUROLOGY (2019)
THE UTILITY OF A SINGLE SIMPLE QUESTION IN THE EVALUATION OF PATIENTS WITH MYASTHENIA GRAVIS
Alon Abraham et al.
MUSCLE & NERVE (2018)
Advances in autoimmune myasthenia gravis management
Shuhui Wang et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2018)
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial (vol 17, pg 35, 2018)
I. N. van Schaik et al.
LANCET NEUROLOGY (2018)
Burden of illness in patients with treatment refractory myasthenia gravis
Nicole M. Engel-Nitz et al.
MUSCLE & NERVE (2018)
Advances in autoimmune myasthenia gravis management
Shuhui Wang et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2018)
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
Ivo N. van Schaik et al.
LANCET NEUROLOGY (2018)
Subcutaneous immunoglobulin in myasthenia gravis exacerbation A prospective, open-label trial
Grayson Beecher et al.
NEUROLOGY (2017)
Myasthenia Gravis Impairment Index Responsiveness, meaningful change, and relative efficiency
Carolina Barnett et al.
NEUROLOGY (2017)
Robust statistical methods: A primer for clinical psychology and experimental psychopathology researchers
Andy P. Field et al.
BEHAVIOUR RESEARCH AND THERAPY (2017)
Subcutaneous immunoglobulin for treatment of multifocal motor neuropathy
Hans D. Katzberg et al.
MUSCLE & NERVE (2016)
Development and validation of the Myasthenia Gravis Impairment Index
Carolina Barnett et al.
NEUROLOGY (2016)
International consensus guidance for management of myasthenia gravis: Executive summary
Donald B. Sanders et al.
NEUROLOGY (2016)
Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study
P. R. Bourque et al.
PLOS ONE (2016)
Myasthenia gravis: subgroup classification and therapeutic strategies
Nils Erik Gilhus et al.
LANCET NEUROLOGY (2015)
Diagnostic and clinical classification of autoimmune myasthenia gravis
Sonia Berrih-Aknin et al.
JOURNAL OF AUTOIMMUNITY (2014)
Maintenance IVIg therapy in myasthenia gravis does not affect disease activity
M. A. Hellmann et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Intravenous immunoglobulin for prophylaxis of acute exacerbation in Myasthenia Gravis
Mine Hayriye Sorgun et al.
NEUROLOGICAL SCIENCES (2014)
Comparison of IVIg and PLEX in patients with myasthenia gravis
D. Barth et al.
NEUROLOGY (2011)
IV immunoglobulin in patients with myasthenia gravis - A randomized controlled trial
Lorne Zinman et al.
NEUROLOGY (2007)
Intravenous immunoglobulin monotherapy in long-term treatment of myasthenia gravis
B Wegner et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2002)
The use of intravenous immunoglobulin as maintenance therapy in myasthenia gravis
O Hilkevich et al.
CLINICAL NEUROPHARMACOLOGY (2001)
分享论文
